In recent years, TAVI (Transcatheter Aortic Valve Implantation) has emerged as a significant innovation in the treatment of aortic valve disease. Particularly for patients where open-heart surgery is deemed risky due to advanced age, co-existing chronic conditions, general anesthesia risks, or an overall health status unsuitable for surgery, TAVI offers a minimally invasive solution. This closed procedure allows for the implantation of a new heart valve via a catheter-based method.